A new variety of wheat has been developed in the laboratory with medical benefits in the areas of bowel health, diabetes and obesity.


Experimental leader Dr Matthew Morell said: “The wheat had a significantly altered starch composition, increasing the amount of amylose from about 25 to 70%.”
 
Morell said having less amylase in the wheat, which is resistant to digestion, means it has potential as a food with a low glycaemic index. He also said that Starch resistant to digestion also generates favourable changes in the gastro-intestinal tract – promoting bowel health and reducing colorectal cancer risk. Animal trials on rats supported the findings.


Science research company CSIRO Plant Industry developed the variety, with its findings published today (28 February) in the international science journal.


Researchers used CSIRO-developed RNAi gene silencing techniques to suppress the expression of two starch-branching enzymes in an experimental wheat.


Director of Food Futures Flagship, Bruce Lee, who worked with CSIRO, said: “These new wheats produce significant levels of resistant starch. They can be incorporated as wholegrain into breads, cereals and other foods, giving us the opportunity to improve human health.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.